Clover Health Investments, Corp. (CLOV) vs Supernus Pharmaceuticals, Inc. (SUPN)
A side-by-side comparison of Clover Health Investments, Corp. and Supernus Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLOV
Clover Health Investments, Corp.
$4.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SUPN
Supernus Pharmaceuticals, Inc.
$42.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CLOV vs SUPN
growth of $100 · dividends reinvested · last 6yCLOV -53.6% (-12.0%/yr)SUPN +80.6% (+10.4%/yr)SUPN compounded faster over this window
CLOV SUPN
CLOV vs SUPN: by the numbers
- •SUPN is the larger company ($2.49B vs $2.38B market cap).
- •Both run net losses; CLOV's is the smaller (-0.74% vs -13.23% net margin).
- •CLOV grew revenue faster over the past five years (21.18% vs 7.78% CAGR).
Metrics side by side
Valuation
| Metric | CLOV | SUPN |
|---|---|---|
| Forward P/E | 82.09 | 16.70 |
| P/S ratio | 0.96 | 2.99 |
| P/B ratio | 6.34 | 2.41 |
| FCF yield | 3.11% | 0.76% |
Profitability
| Metric | CLOV | SUPN |
|---|---|---|
| Gross margin | 18.57% | 88.07% |
| Operating margin | -0.74% | -5.13% |
| Net margin | -0.74% | -13.23% |
| ROE | -4.88% | -10.66% |
| ROIC | -4.62% | -10.24% |
Growth (annualized)
| Metric | CLOV | SUPN |
|---|---|---|
| Revenue CAGR (5Y) | 21.18% | 7.78% |
| FCF CAGR (5Y) | N/A | -30.77% |
| Total return CAGR (5Y) | -8.36% | 9.85% |
Frequently asked
- Which has grown faster, CLOV or SUPN?
- Over the past five years, CLOV grew revenue faster — CLOV at a 21.18% CAGR versus SUPN at 7.78%.
- How have CLOV and SUPN total returns compared?
- Over the past 5 years, CLOV delivered -8.36% and SUPN delivered 9.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Clover Health Investments ROESupernus Pharmaceuticals ROEClover Health Investments operating marginSupernus Pharmaceuticals operating marginClover Health Investments revenue growthSupernus Pharmaceuticals revenue growthClover Health Investments free cash flowSupernus Pharmaceuticals free cash flow
Clover Health Investments & Supernus Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.